When scan sets split into separate rows, MCAs lose the parent schedule. Here is what that costs you and how to fix it.
TRIUMPH-2's Phase 3 data on retatrutide in 1,152 T2D patients challenges every assumption sponsors hold about GLP-1 trial ...
ArkBio receives FDA clearance for AK0406, a drug-Fc conjugate designed to prevent influenza in adults during the upcoming U.S ...
Clinical Solutions hosts ENGAGE 2026 with 250+ attendees exploring clinical data management solutions for FDA compliance and ...
FDA flagged four patient deaths in evenamide's schizophrenia trial. The question isn't the drug, it's why real-time ...
WCG's Activation Intelligence cuts study activation time by 20 hours per trial by reconciling conflicting information across ...
AKIR001 radiopharmaceutical shows no dose-limiting toxicities in eight patients, with imaging confirming selective tumor ...
GCCL and LabConnect sign MOU to streamline cross-regional clinical trial support across North America and Asia-Pacific ...
AI adoption in clinical trials faces validation and governance gaps, not technical doubts. Organizations need process ...
Phage therapy trials for drug-resistant UTIs are advancing with no FDA guidance document, here's why comparator selection and ...
AstraZeneca's HICKORY trial missed its primary endpoint not because efzimfotase alfa didn't work, but because the trial ...
Sponsors must align outsourcing model to development strategy, not vice versa, as new regulatory pathways require faster ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results